{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:42:19Z","timestamp":1791078139824,"version":"4.1.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jhep.2013.07.033","type":"journal-article","created":{"date-parts":[[2013,8,8]],"date-time":"2013-08-08T06:16:49Z","timestamp":1375942609000},"page":"1331-1341","source":"Crossref","is-referenced-by-count":86,"title":["Interferon-stimulated genes and their role in controlling hepatitis C virus"],"prefix":"10.1016","volume":"59","author":[{"given":"Philippe","family":"Metz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Bartenschlager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2013.07.033_b0010","first-page":"1","article-title":"The origin of hepatitis C virus","volume":"369","author":"Simmonds","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jhep.2013.07.033_b0015","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/embor.2009.223","article-title":"Towards a small animal model for hepatitis C","volume":"10","author":"Ploss","year":"2009","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jhep.2013.07.033_b0020","unstructured":"WHO. Hepatitis C, fact sheet N\u00b0164; 2012 [cited; Available from: <http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/>."},{"key":"10.1016\/j.jhep.2013.07.033_b0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2013.07.033_b0030","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jhep.2012.10.005","article-title":"Innate immunity and HCV","volume":"58","author":"Heim","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.07.033_b0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","article-title":"Management of hepatitis C virus infection","volume":"55","author":"EASL Clinical Practice Guidelines","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.07.033_b0040","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.24641","article-title":"An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of liver diseases","volume":"54","author":"Ghany","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.033_b0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1756283X11426895","article-title":"Efficacy and safety of telaprevir in patients with genotype 1 hepatitis C infection","volume":"5","author":"Cunningham","year":"2012","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.jhep.2013.07.033_b0050","first-page":"17","article-title":"Cell culture systems for hepatitis C virus","volume":"369","author":"Steinmann","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jhep.2013.07.033_b0055","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C","volume":"105","author":"Sarasin-Filipowicz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2013.07.033_b0060","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2011.12.055","article-title":"HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons","volume":"142","author":"Thomas","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.07.033_b0065","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/labinvest.3700135","article-title":"Interferon type I gene expression in chronic hepatitis C","volume":"84","author":"Mihm","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2013.07.033_b0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1574-6976.2011.00319.x","article-title":"Failure of innate and adaptive immune responses in controlling hepatitis C virus infection","volume":"36","author":"Thimme","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jhep.2013.07.033_b0075","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1093\/infdis\/jis762","article-title":"Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies","volume":"207","author":"Lauer","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2013.07.033_b0080","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.cell.2010.04.018","article-title":"Peroxisomes are signaling platforms for antiviral innate immunity","volume":"141","author":"Dixit","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2013.07.033_b0085","doi-asserted-by":"crossref","first-page":"14590","DOI":"10.1073\/pnas.1110133108","article-title":"Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus","volume":"108","author":"Horner","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2013.07.033_b0090","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1084\/jem.20080091","article-title":"Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5","volume":"205","author":"Kato","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2013.07.033_b0095","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molcel.2007.11.028","article-title":"Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses","volume":"29","author":"Takahasi","year":"2008","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhep.2013.07.033_b0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.molcel.2007.10.032","article-title":"The C-terminal regulatory domain is the RNA 5\u2032-triphosphate sensor of RIG-I","volume":"29","author":"Cui","year":"2008","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhep.2013.07.033_b0105","doi-asserted-by":"crossref","first-page":"27278","DOI":"10.1074\/jbc.M111.256974","article-title":"Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I)","volume":"286","author":"Binder","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2013.07.033_b0110","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature07106","article-title":"Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA","volume":"454","author":"Saito","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2013.07.033_b0115","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/JVI.02449-08","article-title":"Nucleotide sequences and modifications that determine RIG-I\/RNA binding and signaling activities","volume":"83","author":"Uzri","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0120","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3109\/14653249.2011.579956","article-title":"Granulocyte-macrophage colony-stimulating factor increases the proportion of circulating dendritic cells after autologous but not after allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Eksioglu","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jhep.2013.07.033_b0125","doi-asserted-by":"crossref","first-page":"e27552","DOI":"10.1371\/journal.pone.0027552","article-title":"Innate host response in primary human hepatocytes with hepatitis C virus infection","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2013.07.033_b0130","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2013.07.033_b0135","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/hep.24557","article-title":"Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells","volume":"54","author":"Andrus","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.033_b0140","doi-asserted-by":"crossref","first-page":"11152","DOI":"10.1128\/JVI.01375-10","article-title":"Dissociation of paramyxovirus interferon evasion activities: universal and virus-specific requirements for conserved V protein amino acids in MDA5 interference","volume":"84","author":"Ramachandran","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0145","doi-asserted-by":"crossref","first-page":"11379","DOI":"10.1128\/JVI.76.22.11379-11386.2002","article-title":"The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the targeted degradation of STAT1 by the V protein of the paramyxovirus simian virus 5","volume":"76","author":"Andrejeva","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0150","doi-asserted-by":"crossref","first-page":"11476","DOI":"10.1128\/JVI.76.22.11476-11483.2002","article-title":"Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation","volume":"76","author":"Rodriguez","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0155","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.immuni.2011.05.003","article-title":"Immune signaling by RIG-I-like receptors","volume":"34","author":"Loo","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2013.07.033_b0160","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2009.06.020","article-title":"Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication","volume":"51","author":"Wang","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.07.033_b0165","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.24763","article-title":"Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates","volume":"55","author":"Li","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.033_b0170","first-page":"219","article-title":"Innate immune responses to hepatitis C virus","volume":"369","author":"Schoggins","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jhep.2013.07.033_b0175","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.virol.2009.11.014","article-title":"TLR3-dependent upregulation of RIG-I leads to enhanced cytokine production from cells infected with the parainfluenza virus SV5","volume":"397","author":"Manuse","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2013.07.033_b0180","doi-asserted-by":"crossref","first-page":"e1003330","DOI":"10.1371\/journal.ppat.1003330","article-title":"IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease","volume":"9","author":"Negash","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2013.07.033_b0185","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1073\/pnas.1002301107","article-title":"Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection","volume":"107","author":"Takahashi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jhep.2013.07.033_b0640","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.26443","article-title":"Interferon-lambda polymorphisms and hepatitis C virus clearance revisited","volume":"58","author":"Lupberger","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.033_b0200","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.24580","article-title":"Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures","volume":"54","author":"Marukian","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.033_b0205","doi-asserted-by":"crossref","first-page":"e27866","DOI":"10.1371\/journal.pone.0027866","article-title":"Ribavirin enhances IFN-alpha signalling and MxA expression: a novel immune modulation mechanism during treatment of HCV","volume":"6","author":"Stevenson","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2013.07.033_b0210","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1128\/JVI.78.18.9713-9720.2004","article-title":"Regulation of hepatitis C virus replication by interferon regulatory factor 1","volume":"78","author":"Kanazawa","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0215","doi-asserted-by":"crossref","first-page":"12881","DOI":"10.1128\/JVI.05633-11","article-title":"ISG56 and IFITM1 proteins inhibit hepatitis C virus replication","volume":"85","author":"Raychoudhuri","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0220","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1743-422X-2-80","article-title":"Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication","volume":"2","author":"Zhu","year":"2005","journal-title":"Virol J"},{"key":"10.1016\/j.jhep.2013.07.033_b0225","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1128\/JVI.77.7.3898-3912.2003","article-title":"Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication","volume":"77","author":"Wang","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0230","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1365-2893.2006.00732.x","article-title":"Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication","volume":"13","author":"Itsui","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2013.07.033_b0235","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.ppat.0020059","article-title":"Host-specific response to HCV infection in the chimeric SCID-beige\/Alb-uPA mouse model: role of the innate antiviral immune response","volume":"2","author":"Walters","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2013.07.033_b0240","doi-asserted-by":"crossref","first-page":"e23856","DOI":"10.1371\/journal.pone.0023856","article-title":"Hepatitis C virus infection suppresses the interferon response in the liver of the human hepatocyte chimeric mouse","volume":"6","author":"Tsuge","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2013.07.033_b0245","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1128\/JVI.75.15.7059-7066.2001","article-title":"DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection","volume":"75","author":"Bigger","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0250","doi-asserted-by":"crossref","first-page":"13779","DOI":"10.1128\/JVI.78.24.13779-13792.2004","article-title":"Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees","volume":"78","author":"Bigger","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0255","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/hep.25897","article-title":"IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection","volume":"56","author":"Park","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.033_b0260","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.24489","article-title":"Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees","volume":"54","author":"Barth","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.033_b0265","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1172\/JCI29832","article-title":"Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection","volume":"116","author":"Shin","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2013.07.033_b0270","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.21776","article-title":"Lack of response to exogenous interferon-alpha in the liver of chimpanzees chronically infected with hepatitis C virus","volume":"46","author":"Lanford","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.033_b0275","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/jir.2008.0092","article-title":"The induction of type I interferon production in hepatitis C-infected patients","volume":"29","author":"Pfeffer","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jhep.2013.07.033_b0280","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/hep.25908","article-title":"Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication","volume":"56","author":"Metz","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhep.2013.07.033_b0285","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2012.10.044","article-title":"Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype 1 infection","volume":"144","author":"Lau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.07.033_b0290","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.chom.2012.08.010","article-title":"Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity","volume":"12","author":"Dreux","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhep.2013.07.033_b0295","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/j.gastro.2012.05.044","article-title":"Interferon-gamma-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C","volume":"143","author":"Dill","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.07.033_b0300","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2013.07.033_b0305","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2013.07.033_b0310","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2013.07.033_b0315","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.07.033_b0320","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2013.07.033_b0325","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1053\/j.gastro.2010.07.005","article-title":"A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice","volume":"139","author":"Tillmann","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.07.033_b0330","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jhep.2010.09.019","article-title":"IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy","volume":"54","author":"Abe","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.07.033_b0335","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/j.gastro.2010.11.039","article-title":"Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C","volume":"140","author":"Dill","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.07.033_b0340","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.20130012","article-title":"IL28B expression depends on a novel TT\/-G polymorphism which improves HCV clearance prediction","volume":"210","author":"Bibert","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2013.07.033_b0345","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1128\/JVI.77.2.1092-1104.2003","article-title":"Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons","volume":"77","author":"Lanford","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0350","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/hep.20844","article-title":"Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector","volume":"42","author":"Helbig","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.033_b0355","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jhep.2011.07.026","article-title":"A functional genomic screen reveals novel host genes that mediate interferon-alpha\u2019s effects against hepatitis C virus","volume":"56","author":"Zhao","year":"2012","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jhep.2013.07.033_b0360","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/j.gastro.2013.02.026","article-title":"A genetic screen identifies interferon-alpha effector genes required to suppress hepatitis C virus replication","volume":"144","author":"Fusco","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.07.033_b0365","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.3390\/v4112598","article-title":"DsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection","volume":"4","author":"Dabo","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.jhep.2013.07.033_b0370","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1096\/fj.02-0958rev","article-title":"The dsRNA binding protein family: critical roles, diverse cellular functions","volume":"17","author":"Saunders","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2013.07.033_b0375","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/j.1460-2075.1992.tb05200.x","article-title":"Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2","volume":"11","author":"Chong","year":"1992","journal-title":"EMBO J"},{"key":"10.1016\/j.jhep.2013.07.033_b0380","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1379\/1466-1268(2002)007<0213:VSTROE>2.0.CO;2","article-title":"Visibly stressed: the role of eIF2, TIA-1, and stress granules in protein translation","volume":"7","author":"Anderson","year":"2002","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.jhep.2013.07.033_b0385","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.chom.2012.05.013","article-title":"Dynamic oscillation of translation and stress granule formation mark the cellular response to virus infection","volume":"12","author":"Ruggieri","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhep.2013.07.033_b0390","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1073\/pnas.012485299","article-title":"Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway","volume":"99","author":"Talloczy","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2013.07.033_b0395","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1128\/MCB.20.4.1278-1290.2000","article-title":"NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase","volume":"20","author":"Zamanian-Daryoush","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2013.07.033_b0400","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nature11290","article-title":"Novel role of PKR in inflammasome activation and HMGB1 release","volume":"488","author":"Lu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2013.07.033_b0405","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.antiviral.2009.05.004","article-title":"Translational insensitivity to potent activation of PKR by HCV IRES RNA","volume":"83","author":"Shimoike","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jhep.2013.07.033_b0410","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1073\/pnas.062055699","article-title":"Regulation of PKR and IRF-1 during hepatitis C virus RNA replication","volume":"99","author":"Pflugheber","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2013.07.033_b0415","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI118025","article-title":"Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region","volume":"96","author":"Enomoto","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2013.07.033_b0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2001.0885","article-title":"How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A","volume":"284","author":"Tan","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2013.07.033_b0425","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.chom.2009.11.004","article-title":"Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation","volume":"6","author":"Garaigorta","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhep.2013.07.033_b0430","doi-asserted-by":"crossref","first-page":"e10575","DOI":"10.1371\/journal.pone.0010575","article-title":"Hepatitis C virus controls interferon production through PKR activation","volume":"5","author":"Arnaud","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2013.07.033_b0435","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nsmb.1445","article-title":"Eukaryotic translation initiation machinery can operate in a bacterial-like mode without eIF2","volume":"15","author":"Terenin","year":"2008","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.jhep.2013.07.033_b0440","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1038\/sj.onc.1204744","article-title":"Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein","volume":"20","author":"Delhem","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2013.07.033_b0445","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.285.5424.107","article-title":"Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein","volume":"285","author":"Taylor","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jhep.2013.07.033_b0450","first-page":"113","article-title":"Hepatitis C virus proteins: from structure to function","volume":"369","author":"Moradpour","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jhep.2013.07.033_b0455","doi-asserted-by":"crossref","first-page":"19631","DOI":"10.1074\/jbc.M112.362095","article-title":"S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus","volume":"287","author":"Yount","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2013.07.033_b0460","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","article-title":"The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus","volume":"139","author":"Brass","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2013.07.033_b0465","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/JVI.01531-10","article-title":"The IFITM proteins inhibit HIV-1 infection","volume":"85","author":"Lu","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0470","doi-asserted-by":"crossref","first-page":"e1001258","DOI":"10.1371\/journal.ppat.1001258","article-title":"Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus","volume":"7","author":"Huang","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2013.07.033_b0475","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1111\/j.1365-2893.2011.01452.x","article-title":"Identification of the IFITM3 gene as an inhibitor of hepatitis C viral translation in a stable STAT1 cell line","volume":"18","author":"Yao","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2013.07.033_b0480","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/hep.26066","article-title":"IFITM1 is a tight junction protein that inhibits hepatitis C virus entry","volume":"57","author":"Wilkins","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.033_b0485","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.4049\/jimmunol.145.7.2207","article-title":"TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen","volume":"145","author":"Takahashi","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2013.07.033_b0490","doi-asserted-by":"crossref","first-page":"e1002337","DOI":"10.1371\/journal.ppat.1002337","article-title":"IFITM3 inhibits influenza A virus infection by preventing cytosolic entry","volume":"7","author":"Feeley","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2013.07.033_b0495","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chom.2013.03.006","article-title":"The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry","volume":"13","author":"Amini-Bavil-Olyaee","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"19","key":"10.1016\/j.jhep.2013.07.033_b0500","doi-asserted-by":"crossref","first-page":"10612","DOI":"10.1128\/JVI.01370-13","article-title":"Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment","volume":"87","author":"Paul","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0505","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1074\/jbc.M807261200","article-title":"The N-terminal amphipathic alpha-helix of viperin mediates localization to the cytosolic face of the endoplasmic reticulum and inhibits protein secretion","volume":"284","author":"Hinson","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2013.07.033_b0510","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.febslet.2010.02.041","article-title":"The antiviral protein viperin is a radical SAM enzyme","volume":"584","author":"Duschene","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jhep.2013.07.033_b0515","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/JVI.02113-07","article-title":"Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus","volume":"82","author":"Jiang","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0520","doi-asserted-by":"crossref","first-page":"20452","DOI":"10.1073\/pnas.0911679106","article-title":"The antiviral protein, viperin, localizes to lipid droplets via its N-terminal amphipathic alpha-helix","volume":"106","author":"Hinson","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2013.07.033_b0525","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nsmb1194","article-title":"A general amphipathic alpha-helical motif for sensing membrane curvature","volume":"14","author":"Drin","year":"2007","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.jhep.2013.07.033_b0530","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1099\/vir.0.033860-0","article-title":"Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33","volume":"93","author":"Wang","year":"2012","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0535","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/hep.24542","article-title":"The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A","volume":"54","author":"Helbig","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.07.033_b0540","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1128\/JVI.78.7.3480-3488.2004","article-title":"Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft","volume":"78","author":"Gao","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0545","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.chom.2007.06.009","article-title":"The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts","volume":"2","author":"Wang","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhep.2013.07.033_b0550","doi-asserted-by":"crossref","first-page":"45","DOI":"10.18388\/abp.2005_3485","article-title":"Farnesyl diphosphate synthase; regulation of product specificity","volume":"52","author":"Szkopinska","year":"2005","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.jhep.2013.07.033_b0555","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1017\/S1355838202020617","article-title":"Activation and evasion of the antiviral 2\u2019-5\u2019-oligoadenylate synthetase\/ribonuclease L pathway by hepatitis C virus mRNA","volume":"8","author":"Han","year":"2002","journal-title":"RNA"},{"key":"10.1016\/j.jhep.2013.07.033_b0560","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2010.01.034","article-title":"2\u2019,5\u2019-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro","volume":"392","author":"Ishibashi","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2013.07.033_b0565","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cell.2007.10.057","article-title":"Structure of the dual enzyme Ire1 reveals the basis for catalysis and regulation in nonconventional RNA splicing","volume":"132","author":"Lee","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2013.07.033_b0570","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1126\/science.6165080","article-title":"Interferon action: RNA cleavage pattern of a (2\u2032\u20135\u2032)oligoadenylate\u2013dependent endonuclease","volume":"212","author":"Floyd-Smith","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.jhep.2013.07.033_b0575","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.febslet.2012.11.010","article-title":"The ribonuclease L-dependent antiviral roles of human 2\u2032,5\u2032-oligoadenylate synthetase family members against hepatitis C virus","volume":"587","author":"Kwon","year":"2013","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jhep.2013.07.033_b0580","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1261\/rna.2244210","article-title":"RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP","volume":"16","author":"Malathi","year":"2010","journal-title":"RNA"},{"key":"10.1016\/j.jhep.2013.07.033_b0585","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1073\/pnas.0504754102","article-title":"Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways","volume":"102","author":"Zhao","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2013.07.033_b0590","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1128\/MCB.01466-09","article-title":"Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification","volume":"30","author":"Shi","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2013.07.033_b0595","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1073\/pnas.93.1.211","article-title":"Immunoregulatory properties of ISG15, an interferon-induced cytokine","volume":"93","author":"D\u2019Cunha","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2013.07.033_b0600","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/gut.2009.195545","article-title":"The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response","volume":"59","author":"Broering","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2013.07.033_b0605","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1099\/vir.0.015388-0","article-title":"ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment","volume":"91","author":"Chen","year":"2010","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0610","doi-asserted-by":"crossref","first-page":"e1002289","DOI":"10.1371\/journal.ppat.1002289","article-title":"Hepatitis C virus reveals a novel early control in acute immune response","volume":"7","author":"Arnaud","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2013.07.033_b0615","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1053\/j.gastro.2006.08.043","article-title":"Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection","volume":"131","author":"Randall","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.07.033_b0620","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.4049\/jimmunol.1000098","article-title":"Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A","volume":"185","author":"Kim","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2013.07.033_b0625","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1128\/JVI.79.10.6291-6298.2005","article-title":"New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1","volume":"79","author":"Taylor","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2013.07.033_b0630","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1478-3231.2009.02144.x","article-title":"Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment","volume":"30","author":"Chang","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2013.07.033_b0635","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.virol.2012.03.011","article-title":"Modulation of hepatitis C virus release by the interferon-induced protein BST-2\/tetherin","volume":"428","author":"Dafa-Berger","year":"2012","journal-title":"Virology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813005485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813005485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T19:02:24Z","timestamp":1688410944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827813005485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":125,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0168827813005485"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2013.07.033","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}